295 related articles for article (PubMed ID: 25644941)
1. Identification of rare germline copy number variations over-represented in five human cancer types.
Park RW; Kim TM; Kasif S; Park PJ
Mol Cancer; 2015 Feb; 14():25. PubMed ID: 25644941
[TBL] [Abstract][Full Text] [Related]
2. Contribution of rare germline copy number variations and common susceptibility loci in Lynch syndrome patients negative for mutations in the mismatch repair genes.
Villacis RA; Miranda PM; Gomy I; Santos EM; Carraro DM; Achatz MI; Rossi BM; Rogatto SR
Int J Cancer; 2016 Apr; 138(8):1928-35. PubMed ID: 26620301
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide copy number analysis reveals candidate gene loci that confer susceptibility to high-grade prostate cancer.
Poniah P; Mohd Zain S; Abdul Razack AH; Kuppusamy S; Karuppayah S; Sian Eng H; Mohamed Z
Urol Oncol; 2017 Sep; 35(9):545.e1-545.e11. PubMed ID: 28527622
[TBL] [Abstract][Full Text] [Related]
4. Germline copy number variations are associated with breast cancer risk and prognosis.
Kumaran M; Cass CE; Graham K; Mackey JR; Hubaux R; Lam W; Yasui Y; Damaraju S
Sci Rep; 2017 Nov; 7(1):14621. PubMed ID: 29116104
[TBL] [Abstract][Full Text] [Related]
5. Rare germline alterations in cancer-related genes associated with the risk of multiple primary tumor development.
Villacis RAR; Basso TR; Canto LM; Pinheiro M; Santiago KM; Giacomazzi J; de Paula CAA; Carraro DM; Ashton-Prolla P; Achatz MI; Rogatto SR
J Mol Med (Berl); 2017 May; 95(5):523-533. PubMed ID: 28093616
[TBL] [Abstract][Full Text] [Related]
6. Large germline copy number variations as predisposing factor in childhood neoplasms.
Krepischi AC; Capelli LP; Silva AG; de Araújo ÉS; Pearson PL; Heck B; da Costa CM; de Camargo B; Rosenberg C
Future Oncol; 2014; 10(9):1627-33. PubMed ID: 25145432
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide expression profiling-based copy number variations and colorectal cancer risk in Chinese.
Wang K; Yu X; Jiang H; Huang J; Wang H; Jiang H; Wei S; Liu L
Mol Carcinog; 2019 Jul; 58(7):1324-1333. PubMed ID: 31001878
[TBL] [Abstract][Full Text] [Related]
8. A genome-wide association study of copy-number variation identifies putative loci associated with osteoarthritis in Koreans.
Moon S; Keam B; Hwang MY; Lee Y; Park S; Oh JH; Kim YJ; Lee HS; Kim NH; Kim YJ; Kim DH; Han BG; Kim BJ; Lee J
BMC Musculoskelet Disord; 2015 Apr; 16():76. PubMed ID: 25880085
[TBL] [Abstract][Full Text] [Related]
9. A Genome-Wide Association Study to Identify Potential Germline Copy Number Variants for Sporadic Breast Cancer Susceptibility.
Sapkota Y; Narasimhan A; Kumaran M; Sehrawat BS; Damaraju S
Cytogenet Genome Res; 2016; 149(3):156-164. PubMed ID: 27668787
[TBL] [Abstract][Full Text] [Related]
10. Candidate predisposing germline copy number variants in early onset colorectal cancer patients.
Brea-Fernandez AJ; Fernandez-Rozadilla C; Alvarez-Barona M; Azuara D; Ginesta MM; Clofent J; de Castro L; Gonzalez D; Andreu M; Bessa X; Llor X; Xicola R; Jover R; Castells A; Castellvi-Bel S; Capella G; Carracedo A; Ruiz-Ponte C
Clin Transl Oncol; 2017 May; 19(5):625-632. PubMed ID: 27888432
[TBL] [Abstract][Full Text] [Related]
11. Germline copy number variations in BRCA1-associated ovarian cancer patients.
Yoshihara K; Tajima A; Adachi S; Quan J; Sekine M; Kase H; Yahata T; Inoue I; Tanaka K
Genes Chromosomes Cancer; 2011 Mar; 50(3):167-77. PubMed ID: 21213370
[TBL] [Abstract][Full Text] [Related]
12. Frequency of germline genomic homozygosity associated with cancer cases.
Assié G; LaFramboise T; Platzer P; Eng C
JAMA; 2008 Mar; 299(12):1437-45. PubMed ID: 18364486
[TBL] [Abstract][Full Text] [Related]
13. Increased genomic burden of germline copy number variants is associated with early onset breast cancer: Australian breast cancer family registry.
Walker LC; Pearson JF; Wiggins GA; Giles GG; Hopper JL; Southey MC
Breast Cancer Res; 2017 Mar; 19(1):30. PubMed ID: 28302160
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer associated germline structural variants harboring small noncoding RNAs impact post-transcriptional gene regulation.
Kumaran M; Krishnan P; Cass CE; Hubaux R; Lam W; Yasui Y; Damaraju S
Sci Rep; 2018 May; 8(1):7529. PubMed ID: 29760470
[TBL] [Abstract][Full Text] [Related]
15. Role of rare germline copy number variation in melanoma-prone patients.
Fidalgo F; Rodrigues TC; Silva AG; Facure L; de Sá BC; Duprat JP; Achatz MI; Rosenberg C; Carraro DM; Krepischi AC
Future Oncol; 2016 Jun; 12(11):1345-57. PubMed ID: 27020340
[TBL] [Abstract][Full Text] [Related]
16. The landscape of copy number variations in Finnish families with autism spectrum disorders.
Kanduri C; Kantojärvi K; Salo PM; Vanhala R; Buck G; Blancher C; Lähdesmäki H; Järvelä I
Autism Res; 2016 Jan; 9(1):9-16. PubMed ID: 26052927
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide rare copy number variations contribute to genetic risk for transposition of the great arteries.
Costain G; Lionel AC; Ogura L; Marshall CR; Scherer SW; Silversides CK; Bassett AS
Int J Cardiol; 2016 Feb; 204():115-21. PubMed ID: 26655555
[TBL] [Abstract][Full Text] [Related]
18. Rare Germline Copy Number Variations and Disease Susceptibility in Familial Melanoma.
Shi J; Zhou W; Zhu B; Hyland PL; Bennett H; Xiao Y; Zhang X; Burke LS; Song L; Hsu CH; Yan C; Chen Q; Meerzaman D; Dagnall CL; Burdette L; Hicks B; Freedman ND; Chanock SJ; Yeager M; Tucker MA; Goldstein AM; Yang XR
J Invest Dermatol; 2016 Dec; 136(12):2436-2443. PubMed ID: 27476724
[TBL] [Abstract][Full Text] [Related]
19. A genome-wide assessment of rare copy number variants in colorectal cancer.
Li Z; Yu D; Gan M; Shan Q; Yin X; Tang S; Zhang S; Shi Y; Zhu Y; Lai M; Zhang D
Oncotarget; 2015 Sep; 6(28):26411-23. PubMed ID: 26315111
[TBL] [Abstract][Full Text] [Related]
20. Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci.
DeVries AA; Dennis J; Tyrer JP; Peng PC; Coetzee SG; Reyes AL; Plummer JT; Davis BD; Chen SS; Dezem FS; Aben KKH; Anton-Culver H; Antonenkova NN; Beckmann MW; Beeghly-Fadiel A; Berchuck A; Bogdanova NV; Bogdanova-Markov N; Brenton JD; Butzow R; Campbell I; Chang-Claude J; Chenevix-Trench G; Cook LS; DeFazio A; Doherty JA; Dörk T; Eccles DM; Eliassen AH; Fasching PA; Fortner RT; Giles GG; Goode EL; Goodman MT; Gronwald J; ; ; Håkansson N; Hildebrandt MAT; Huff C; Huntsman DG; Jensen A; Kar S; Karlan BY; Khusnutdinova EK; Kiemeney LA; Kjaer SK; Kupryjanczyk J; Labrie M; Lambrechts D; Le ND; Lubiński J; May T; Menon U; Milne RL; Modugno F; Monteiro AN; Moysich KB; Odunsi K; Olsson H; Pearce CL; Pejovic T; Ramus SJ; Riboli E; Riggan MJ; Romieu I; Sandler DP; Schildkraut JM; Setiawan VW; Sieh W; Song H; Sutphen R; Terry KL; Thompson PJ; Titus L; Tworoger SS; Van Nieuwenhuysen E; Edwards DV; Webb PM; Wentzensen N; Whittemore AS; Wolk A; Wu AH; Ziogas A; Freedman ML; Lawrenson K; Pharoah PDP; Easton DF; Gayther SA; Jones MR
J Natl Cancer Inst; 2022 Nov; 114(11):1533-1544. PubMed ID: 36210504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
